Press Releases

Tanzi Discusses "Alzheimer's Genome Project" at International Alzheimer's Conference

Map of Alzheimer’s Genes May Lead to Novel Therapies

Dr. Rudolph Tanzi Speaks at International Conference on Alzheimer’s

Breakthrough genetic research to map all the genes connected to Alzheimer’s, which could lead to more aggressive treatment and a potential cure for the disease, was the focus of a presentation by leading Alzheimer’s researcher Dr. Rudolph Tanzi at the International Conference on Alzheimer’s Disease (ICAD) in Chicago.

Tanzi Testifies Before Senate on Latest Progress of Fast-Track Effort to Map Genes for Alzheimer's

Dr. Tanzi Testifies Before Senate

Washington, May 14, 2008 – Mapping the sequence of the genes susceptible to Alzheimer’s disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimer’s early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, told the Senate Special Committee on Aging at a hearing today on the disease.

Scaling Heights to Cure Alzheimer's

Mountaineer to Raise Awarness, Research Funding for Alzheimer's on Road Back to Everest

Boston - Embarking on a yearlong challenge that he hopes will end at the top of Mt. Everest, mountain climber Alan Arnette will take on a greater challenge along his journey, raising money for research and public awareness of Alzheimer’s disease.

Coalition of Alzheimer's Organizations Announces New "Genius Grant" for Younger Researchers

In an effort to support the next generation of leading Alzheimer's researchers, the Cure Alzheimer's Fund has joined with the Alzheimer's Association and the Lou Ruvo Brain Institute to create and fund a new "genius grant" for young Alzheimer's researchers.

Cure Alzheimer's Fund's Dr.Tanzi Briefs Congress on Research Progress, Rep. Markey Praises Fund

Washington – With more than 5 million Americans now living with Alzheimer’s disease, a 10 percent increase since 2002, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s in hopes of leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease.

Cure Alzheimer's Fund's Dr. Rudy Tanzi Honored as Top Researcher by the Alzheimer's Association

Washington – In recognition of his groundbreaking genetic research and outstanding leadership and commitment to finding a cure and better treatment for Alzheimer’s disease, Dr. Rudolph Tanzi received the 2007 Ronald and Nancy Reagan Award at the Alzheimer’s Association’s National Gala this week.

Massachusetts General Hospital Honors Cure Alzheimer's Fund with First-Ever Philanthropic Award

Boston – Massachusetts General Hospital (MassGeneral) has honored Cure Alzheimer’s FundTM for its leadership, entrepreneurial philanthropy and investment in research projects that have the highest probability of slowing, stopping or reversing Alzheimer's disease. The first annual Award for “Philanthropic Innovation and Investment” was presented to the Fund by MassGeneral’s Institute for Neurodegenerative Disease, at a ceremony at Massachusetts General Hospital on Friday, March 2.

New Web-based Alzheimer's Disease Genetic Research Clearinghouse Launched

First-of-its-Kind Online Resource ( Offers Researchers an Extensive Database of Studies on the Genes Associated with Alzheimer's Risk

Boston, MA – AlzGene, a web-based clearinghouse for researchers working to unlock the genetic makeup of Alzheimer’s Disease, has been launched as a way to gather and analyze studies by and for investigators around the world. The project aims to bring clarity to the increasingly prolific and confusing field of Alzheimer’s genetics research.

100 Years of Alzheimer's Disease Discovery November 6, 1906

Fast-Track Research Effort Hopes to Map Genes Affecting Risk for Alzheimer’s Disease within 18 Months

Is A Cure Around the Corner?

Private-Venture Philanthropy Model Changing the Face of Medical Research

BOSTON – On the eve of the 100th anniversary of the discovery of Alzheimer’s disease, medical researchers are in a sprint to map and sequence the genes susceptible to Alzheimer’s, leading to more aggressive therapeutic interventions to slow, stop or even reverse the effects of the disease. It is a race that must be won in the next few years if we are to save up to 16 million baby boomers from the devastation of the disease, says Dr. Rudolph Tanzi, lead researcher for the Cure Alzheimer’s Fund.

World-Renowned Harvard Alzheimer's Doctor Discusses Latest Alzheimer's Research on Martha's Vineyard

Massachusetts to Face 40% Increase in Alzheimer’s Cases by 2050

Dr. Rudolph E. Tanzi, Ph.D., Director of Aging Research, Harvard Medical School Chair of the Cure Alzheimer’s Fund’s Research Consortium

Hyannis Port, Mass. --- Up to 16 million Americans and 350,000 Massachusetts residents could have Alzheimer’s disease by the year 2050 if a prevention or cure is not found during the next few years was the key message of a presentation by Dr. Rudolph E. Tanzi, Director of the Genetics and Aging Research Unit at Massachusetts General Hospital/Harvard Medical School, August 3 at the Martha’s Vineyard home of Jacqui and Jeff Morby, two of the founders of Cure Alzheimer’s fund.